Bodduluri Haribabu mainly investigates Cell biology, Receptor, Chemotaxis, Inflammation and Chemokine receptor. The concepts of his Cell biology study are interwoven with issues in Internalization and Gut flora. His Receptor research is multidisciplinary, relying on both Molecular biology and Signal transduction.
His Chemotaxis study integrates concerns from other disciplines, such as Immunology, Monocyte, Leukotriene B4 and Eicosanoid. The study incorporates disciplines such as CD36 and Pharmacology in addition to Immunology. Many of his research projects under Inflammation are closely connected to Trophoblast, Placenta and Syncytiotrophoblast with Trophoblast, Placenta and Syncytiotrophoblast, tying the diverse disciplines of science together.
His scientific interests lie mostly in Cell biology, Immunology, Receptor, Leukotriene B4 and Inflammation. His studies in Cell biology integrate themes in fields like Internalization, Chemotaxis, Chemokine receptor and Biochemistry. He combines subjects such as Platelet-activating factor, Exocytosis and Dendritic cell migration with his study of Chemotaxis.
Bodduluri Haribabu interconnects Molecular biology, Signal transduction and Phosphorylation in the investigation of issues within Receptor. He has included themes like Gene expression, Phagocytosis, E-selectin and Eicosanoid in his Leukotriene B4 study. His Inflammation research is multidisciplinary, incorporating elements of Tumor progression, Arachidonic acid, Cell growth and Silicosis.
Bodduluri Haribabu mostly deals with Cell biology, Immunology, Cancer research, Inflammation and Gut flora. His Effector study in the realm of Cell biology connects with subjects such as Yersinia pestis. His work on Chemokine and Chemokine receptor is typically connected to Mucosal healing as part of general Immunology study, connecting several disciplines of science.
His Inflammation research focuses on Leukotriene B4 in particular. The various areas that he examines in his Gut flora study include Microbiome, Barrier function and Bacteria. His study looks at the intersection of Adoptive cell transfer and topics like CD8 with Antigen presentation, Adenomatous polyposis coli, Mast cell and Receptor.
Bodduluri Haribabu mainly focuses on Gut flora, Inflammation, Immunology, Cell biology and Microbiome. His Gut flora research is multidisciplinary, incorporating perspectives in Genetics and Bacteroides. His work is dedicated to discovering how Inflammation, Cell growth are connected with Leukotriene B4, Lung cancer, Lung, Chemokine and Silicosis and other disciplines.
His Immunology research integrates issues from Endothelium and Colorectal cancer. His biological study spans a wide range of topics, including Microvesicles and Caco-2. His research in Microbiome intersects with topics in Ecology, Cecum, Endocrinology and Antibiotics.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Regulation of human chemokine receptors CXCR4: Role of phosphorylation in desensitization and internalization
Bodduluri Haribabu;Ricardo M. Richardson;Ian Fisher;Silvano Sozzani.
Journal of Biological Chemistry (1997)
Chemoattractant Receptor Cross-desensitization *
Hydar Ali;Ricardo M. Richardson;Bodduluri Haribabu;Ralph Snyderman.
Journal of Biological Chemistry (1999)
Lipid-Cytokine-Chemokine Cascade Drives Neutrophil Recruitment in a Murine Model of Inflammatory Arthritis
Richard C. Chou;Nancy D. Kim;Christian D. Sadik;Edward Seung.
Plant-Derived Exosomal MicroRNAs Shape the Gut Microbiota
Yun Teng;Yi Ren;Mohammed Sayed;Xin Hu.
Cell Host & Microbe (2018)
Evidence for a link between gut microbiota and hypertension in the Dahl rat
Blair Mell;Venkatakrishna R. Jala;Anna V. Mathew;Jaeman Byun.
Physiological Genomics (2015)
Enhancement of the gut barrier integrity by a microbial metabolite through the Nrf2 pathway
Rajbir Singh;Sandeep Chandrashekharappa;Sobha R. Bodduluri;Becca V. Baby.
Nature Communications (2019)
A point mutation that confers constitutive activity to CXCR4 reveals that T140 is an inverse agonist and that AMD3100 and ALX40-4C are weak partial agonists.
Wen-bo Zhang;Jean-Marc Navenot;Bodduluri Haribabu;Hirokazu Tamamura.
Journal of Biological Chemistry (2002)
Role of Leukotriene B4 Receptors in the Development of Atherosclerosis: Potential Mechanisms
Krishnaprasad Subbarao;Venkatakrishna R. Jala;Steven Mathis;Jill Suttles.
Arteriosclerosis, Thrombosis, and Vascular Biology (2004)
Human calcium-calmodulin dependent protein kinase I: cDNA cloning, domain structure and activation by phosphorylation at threonine-177 by calcium-calmodulin dependent protein kinase I kinase.
B Haribabu;S S Hook;M A Selbert;E G Goldstein.
The EMBO Journal (1995)
Targeted Disruption of the Leukotriene B4Receptor in Mice Reveals Its Role in Inflammation and Platelet-Activating Factor–Induced Anaphylaxis
Bodduluri Haribabu;Margrith W. Verghese;Douglas A. Steeber;Dwight D. Sellars.
Journal of Experimental Medicine (2000)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: